Concepedia

Toxicity Rechallenge

Toxicity Rechallenge is a clinical intervention strategy in which a therapeutic agent previously discontinued due to toxicity is reintroduced after resolution or management of the adverse effect, typically to assess tolerability or maintain treatment efficacy under controlled conditions.

17

Publications

480

Citations

152

Authors

72

Institutions

Publications per year

2017–2026

8

Parents

Publications

17

Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?

Heidar Albandar, Jacob Fuqua, Jasim M. Albandar et al. · Cancers · 2021 · 69 citations · Full text

, , +17

Gemfibrozil-Induced Myopathy

Gregory J. Magarian · Archives of Internal Medicine · 1991 · 64 citations

, , +11

First-line chemotherapy rechallenge after relapse in small cell lung cancer

Mark Vincent, Barrie Evans, Ian Smith · Cancer Chemotherapy and Pharmacology · 1988 · 55 citations

, , +10

Serious Adverse Reactions Associated With Sulindac

Glen D. Park · Archives of Internal Medicine · 1982 · 52 citations

, , +16

Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer

Federico Cappuzzo, Alessandro Morabito, Nicola Normanno et al. · Lung Cancer · 2016 · 38 citations

, , +12

1–5 of 17

Authors

152

  1. DC
    David Cunningham

    Royal Marsden Hospital, United Kingdom

    2 publications · 27 citations

    2

    h-index

  2. IC
    Ian Chau

    Royal Marsden NHS Foundation Trust, United Kingdom

    2 publications · 27 citations

    2

    h-index

  3. MB
    Muhammet Bekir Hacıoğlu

    Trakya University, Türkiye

    1 publications · 36 citations

    1

    h-index

  4. MD
    M. Durand

    Institut Bergonié, France

    1 publications · 14 citations

    1

    h-index

  5. NM
    Norikazu Matsuo

    Kurume University, Japan

    1 publications · 23 citations

    1

    h-index

1–5 of 152

Institutions

72

  1. Institut Bergonié

    Bordeaux, France

    3 h-index

    12 publications

    178 citations

  2. Royal Marsden Hospital

    London, United Kingdom

    3 h-index

    16 publications

    344 citations

  3. Royal Marsden NHS Foundation Trust

    London, United Kingdom

    2 h-index

    4 publications

    182 citations

  4. Università degli Studi del Piemonte Orientale “Amedeo Avogadro”

    Vercelli, Italy

    2 h-index

    2 publications

    61 citations

  5. Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

    Naples, Italy

    2 h-index

    4 publications

    139 citations

  6. IRCCS Humanitas Research Hospital

    Rozzano, Italy

    1 h-index

    1 publications

    38 citations

  7. Centre Léon Bérard

    Lyon, France

    1 h-index

    1 publications

    10 citations

  8. University of Washington Medical Center

    Seattle, United States

    1 h-index

    4 publications

    92 citations

1–8 of 72

Venues

  1. Archives of Internal Medicine

    2 publications · 88 citations

    2

    h-index

  2. PubMed

    Repository · 2 publications · 37 citations

    2

    h-index

  3. Cancer Chemotherapy and Pharmacology

    2 publications · 91 citations

    2

    h-index

  4. Clinical Colorectal Cancer

    2 publications · 35 citations

    2

    h-index

  5. Medical Oncology

    MO · 1 publications · 23 citations

    1

    h-index

1–5